No Data
No Data
Leerink Partners Maintains Tenet Healthcare(THC.US) With Buy Rating, Cuts Target Price to $185
Strong Buy Recommendation for Tenet Healthcare: Undervalued Stock With Robust Growth Potential and Positive Financial Outlook
Tenet Healthcare's 2024 Earnings Call Highlights Growth and Challenges
Tenet Healthcare Price Target Maintained With a $177.00/Share by Cantor Fitzgerald
Tenet Q4 Earnings Beat Estimates on Favorable Payer Mix
Barclays Maintains Overweight on Tenet Healthcare, Lowers Price Target to $161